M&A Deal Summary

Xanodyne Pharmacal Acquires Integrity Pharmaceutical

On February 9, 2004, Xanodyne Pharmacal acquired life science company Integrity Pharmaceutical

Acquisition Highlights
  • This is Xanodyne Pharmacal’s 1st transaction in the Life Science sector.
  • This is Xanodyne Pharmacal’s 1st transaction in the United States.
  • This is Xanodyne Pharmacal’s 1st transaction in Indiana.

M&A Deal Summary

Date 2004-02-09
Target Integrity Pharmaceutical
Sector Life Science
Buyer(s) Xanodyne Pharmacal
Deal Type Add-on Acquisition
Advisor(s) Junewicz & Co. (Financial)

Target

Integrity Pharmaceutical

Fishers, Indiana, United States
Integrity Pharmaceutical is a manufacturer specialty Pharma – women's health.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Xanodyne Pharmacal

Florence, Kentucky, United States

Category Company
Sector Life Science
DESCRIPTION


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Indiana M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2004 M&A 1 of 1